Extended-release naltrexone to prevent opioid relapse in criminal justice offenders Academic Article uri icon

Overview

MeSH Major

  • Criminals
  • Naltrexone
  • Narcotic Antagonists
  • Opioid-Related Disorders

abstract

  • In this trial involving criminal justice offenders, extended-release naltrexone was associated with a rate of opioid relapse that was lower than that with usual treatment. Opioid-use prevention effects waned after treatment discontinuation. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00781898.).

publication date

  • March 31, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5454800

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1505409

PubMed ID

  • 27028913

Additional Document Info

start page

  • 1232

end page

  • 42

volume

  • 374

number

  • 13